×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
HEALTH ECONOMICS OUTCOME RESEARCH (HEOR)
Session Chair(s)
Markus Hartmann, PhD, RAC
Head of Data Value Office-R&D Digital Data Transformation
Merck KGaA, Germany
Learning Objective : Recognize the potential disconnect between what patients want to participate in clinical trials and the processes that sponsors must follow for data to be valid. Identify the solutions that provide validity to outcomes research that will benefit both patients and sponsors.
Speaker(s)
Partnering with Patients: Designing, participating in and reporting health outcomes
Judith Teall, RN
Independent Consultant, United Kingdom
The new interface between regulators and HTA bodies: common or divergent expectations for health outcomes data?
Markus Hartmann, PhD, RAC
Merck KGaA, Germany
Head of Data Value Office-R&D Digital Data Transformation
Collecting Clinical Data to meet Payers and HTA Bodies’ Requirements
Simone Breitkopf
Alcon Pharma GmbH, Germany
Head Governmental Affairs and Pricing
Have an account?